Summary of Product Characteristics
last updated on the eMC:
19/08/2009
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 19/08/2009 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 1 -Name of the Medicinal product
-
Change to section 2 - Qualitative and quantitative composition
-
Change to section 3 - Pharmaceutical form
-
Change to section 6. 4 - Special Precautions for Storage
-
Change to section 6. 6 - Instructions for use, handling and disposal
-
Change to section 10 date of revision of the text
|
| Date of revision of text on the SPC: 01-Aug-2007 |
| Legal Category: P |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
Section 1
Name changed from Glytrin Spray to Glytrin, 400 micrograms per metered dose, Sublingual Spray
Section 2
Following information added;
This product contains small amounts of ethanol (alcohol) less than 100mg per spray.
For full list of excipients, see Section 6.1
Following information removed;
On emetered dose with 8.8mg solution contains 400 micrograms glycerol trinitrate
Section 3
Folloiwing information added;
Metered dose oromucosal (sublingual) spray solution.
Small aerosol canister
Following information removed;
Sublingual spray
Section 6.4
Following information added;
Do not refrigerate or freeze.
Following information removed;
Protect from frost and direct heat or sunlight
Section 6.6
Following information added;
Glytrin is an aerosol spray and contains a pressurized liquid. Do not expose to temperature higher than 50ºC, and do not pierce the canister, even when empty. It should not be sprayed at a naked flame or any incandescent material. Patients, especially those who smoke, should be warned not to use Glytrin near a naked flame.
Following information removed;
Glytrin SPray is a pressurised container, which must not be pierced or bunt even after use. It should not be sprayed at a naked flame or any incandescent material. Patients, especially those who smoke should be warned not to use Glytrin Spray near a naked flame.
|
|
Updated on 05/07/2007 and displayed until 19/08/2009
|
Reasons for adding or updating:
|
-
Change to section 4.8 - Undesirable Effects
|
| Date of revision of text on the SPC: 09/2006 |
| Legal Category: P |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| Addition of tongue blistering as an adverse reaction
|
|
Updated on 23/08/2006 and displayed until 05/07/2007
|
Reasons for adding or updating:
|
-
Change from BAN to rINN
-
Change to section 10 (date of (partial) revision of the text
|
| Date of revision of text on the SPC: 03/2005 |
| Legal Category: P |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| Change of active ingrediant from bANN to rINN
|
|
Updated on 12/09/2003 and displayed until 23/08/2006
|
Reasons for adding or updating:
|
-
Change to section 7 - Marketing Authorisation Holder
|
|
Updated on 26/09/2002 and displayed until 12/09/2003
|
Reasons for adding or updating:
|
-
New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC
|
|